Bookmark list

Phenomenex to be Acquired by Danaher Corporation

12-Oct-2016 - USA

Phenomenex Inc. announced it has signed a definitive agreement to be acquired by Danaher Corporation. Phenomenex will operate as a standalone operating company, retaining the Phenomenex brand, its personnel and site locations.

"Phenomenex is a widely recognizable brand that we are proud to say is highly respected and well established as providing high-quality consumables to the scientific community worldwide," said Fasha Mahjoor, CEO, Phenomenex. "Joining Danaher will allow us to maintain the high pace of innovation that our customers and international distributors have come to expect from us. This is our opportunity to further expand our R&D activities, benefit our customers with a more diversified product portfolio and reinforce our market leadership."

"We are thrilled to have Phenomenex join Danaher's life sciences portfolio of businesses, which include SCIEX, Beckman Coulter Life Sciences, Pall, Leica Microsystems and Molecular Devices," said Dan Daniel, Executive Vice President, Danaher. "Phenomenex is a strong business characterized by high growth rates and margins and excellent growth prospects driven by increasing analytical testing needs in the health, research and environmental segments. The Danaher Business System (DBS) has a strong track record of helping businesses rapidly scale operations and create long-term customer value. We look forward to supporting the Phenomenex team in leveraging DBS tools for growth and welcoming them to our Life Sciences team."

The transaction, which is expected to close by late 2016, is subject to customary closing conditions and regulatory approvals.

https://www.bionity.com/en/news/160179/phenomenex-to-be-acquired-by-danaher-corporation.html

Get the life science industry in your inbox

Phenomenex to be Acquired by Danaher Corporation

Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany

Other news from the department business & finance

Good overall result and revenue growth for the ZEISS Group

Merck to Acquire HUB Organoids Holding B.V.

Start-up EBViously founded

For better leukemia therapies: spin-off Cimeio partners with pharmaceutical company Kyowa Kirin

Lindis Blood Care announces successful financing for its tumour-cell-removal medical device

AQEMIA hits $100 million funding milestone

Concept Life Sciences and Accelero Biostructures partner to advance X-ray crystallography in early drug discovery

Orikine Bio secures €800k in innovation research funding to advance groundbreaking autoimmune disease therapy

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser to market

Refoxy Pharmaceuticals raises €9.1 million to progress its novel FOXO3 therapeutics for Idiopathic Pulmonary Fibrosis

miDiagnostics secures €30 million Series D funding round led by Thermo Fisher Scientific

Capitainer participates in global AI project for advanced lung diagnostics

Eppendorf SE and DataHow AG announce strategic collaboration to advance bioprocess data management

IDEAward for researchers’ start-up ideas

Start-up aims to bring AI-powered protein engineering to every lab

Roche acquires Poseida Therapeutics

Körber acquires Bähren Pharma-Packaging

Bayer further expands global incubator network with Bayer Co.Lab Berlin and welcomes MyoPax as first resident

QIAGEN Strengthens QIAstat-Dx With New Barcelona Site

Belgian start-up BIO INX and Carl ROTH partner to expand access to 3D bioprinting solutions

Get the life science industry in your inbox

Most read news

Microbe of the Year 2023: Bacillus subtilis – for health and technology

A new era of allergy treatment

CRISPR-Cas technology: ETH researchers have uncovered a serious side effect

‘Love hormone’ instead of opioids

Designing large new proteins with AI

Delivering medicines with microscopic flowers

Brain tumour cells rapidly integrate into brain-wide neuronal circuits

A stronghold in the fight against viruses - new bacterial immune system decoded

Concept Life Sciences and Accelero Biostructures partner to advance X-ray crystallography in early drug discovery

Cancer research: Small change with a big impact

From chip shop to pit stop

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser to market

More news from our other portals

Recycling batteries with citric acid

The science behind Magnum Bon Bon bite-sized ice creams

MIT gel changes color on demand

Plastic fantastic: Green, strong and edible

Food labeling in the EU is often misleading

Chemical analyses faster and more precise than ever before

Breakthrough in zinc-based rechargeable batteries: A safer, sustainable alternative

Beer like the Romans

Surfaces and Interfaces: Innovative techniques allow researchers to study interfaces with great precision

New method for new materials

Risk assessment: Essential ingredient for greater food safety

Smarter sensor sniffs out target gases

Researchers develop a new material that removes a dangerous “forever chemical,” from drinking water

Can AI improve plant-based meats?

Portable kit can recover traces of chemical evidence

Renewable Carbon Feedstocks: Building a Net-Zero Chemical Industry in 2050

Young people most stressed about spending family time this Christmas

Fresh iron from old mining sludge

Robots work in the bakery

Advanced Automation Technologies agrees to acquire GERSTEL

Why coffee needs an extra shot of Taylor Swift

Breakthrough: Previously unknown compound in chloraminated drinking water identified

Airy, delicious pastries with food foam made from peas

Liquid water molecules are inherently asymmetric

Color-Changing Test for Rapid Salmonella Detection

All FT-IR spectrometer manufacturers at a glance